About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

REnAL denervatIon by ultraSound Transcatheter Emission

NCT01529372·2 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

ReCor Medical, Inc.

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Resistant hypertension, as defined in the 2007 ESH-ESC guidelines
18 years of age or older
Negative pregnancy test for female patients of childbearing potential
Willing and able to comply with follow-up requirements
Signed informed consent

You may not be if

Secondary hypertension
Main renal arteries length \< 20 mm
Main renal arteries diameter \< 4 mm
Renal artery stenosis
Iliac/femoral artery stenosis precluding insertion of the catheter
Allergy to contrast media
Currently participating in the study of an investigational drug or device
Hemodynamics abnormality
Moderate to severe renal insufficiency

The record

StatusCompleted

PhaseNo phase

Taking part20

StartedMay 2012

UpdatedJul 6, 2018

Conditions

Resistant Hypertension

Where2

Université de Toulouse et CHU
Toulouse, France
Hôpital Pitié-Salpêtrière
Paris, Île-de-France Region, France

Clareo Health | REnAL denervatIon by ultraSound Transcatheter Emission